期刊文献+

辛伐他汀对低氧培养的内皮细胞合成和分泌内皮素-1的影响 被引量:5

Effect of Simvastatin on Endothelin-1 Expression in Endothelial Cell Cultured Hypoxically
下载PDF
导出
摘要 目的观察羟甲基戊二酰辅酶A(HMG-COA)还原酶抑制剂辛伐他汀对低氧培养的内皮细胞合成和分泌内皮素-1(ET-1)的影响。方法低氧培养人脐静脉内皮细胞,采用辛伐他汀以不同浓度(0、1、2.5、5.0、10.0μmol/L)和不同作用时间(12、24、48h)进行干预,并用甲羟戊酸(100μmol/L)调节辛伐他汀的作用。采用半定量逆转录聚合酶链反应(RT-PCR)检测内皮细胞ET-1mRNA的表达;采用酶联免疫吸附试验(ELISA)检测内皮细胞上清液中ET-1蛋白的浓度。结果11μmol/L浓度的辛伐他汀对内皮细胞ET-1mRNA和ET-1蛋白表达没有影响,2.5μmol/L辛伐他汀即可抑制ET-1的表达,但与0μmol/L浓度组相比差异无统计学意义;5μmol/L及10μmol/L辛伐他汀则表现出明显的抑制作用(P<0.01),尤以10μmol/L浓度组明显;2以10μmol/L辛伐他汀干预低氧培养的内皮细胞,低氧12h后,内皮细胞ET-1mRNA和ET-1蛋白表达明显减少,24h后继续降低,48h达到最低;3100μmol/L甲羟戊酸可以阻止辛伐他汀对低氧培养的内皮细胞合成和分泌ET-1的抑制作用。结论辛伐他汀对低氧培养的内皮细胞合成和分泌ET-1具有抑制作用。 Objective To observe the role of simvasatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in synthesis and excretion of endothelin-1 (ET-1) in endothelial cell cultured hypoxically. Methods Human umbilical vein endothelial cells were hypoxically cultured and treated with simvastatin by different concentrations (0,1.0,2.5,5.0,10. 0μmol/L) and different times (12,24,48 h). Mevalonate was used to intervent the effect of simvastatin. Reverse transcription-polymerase chain reaction (RT-PCR)and enzyme-linked immunoadsorbent assay (ELISA) were adopted to measure ET-1 mRNA and ET-1 in supernatant fluid of endothelial cell culture. Results (1)There were no changes of ET-1 mRNA and ET-1 expression after the hypoxically cultured endothelial cell were incubated with 1 μmol/L simvastatin, but ET-1 expression decreased without significant difference compared to control (0 μmol/L simvastatin) when interfered with 2. 5 μmol/Lsimvastatin. The decreases of ET-1 mRNA and ET-1 expression became more obvious when expression were interfered by 5 μmol/Land 10 μmol/L simvastatin(P〈0. 01). (2) ET-1 mRNA and ET-1 expression decreased at 12 h after the endothelial cells were incubated with 10 μmol/L simvastatin, which became more fewer at 24 h and reached the minimum expression at 48 h (P〈0. 01). (3) The inhibition effect of simvastatin on ET-1 mRNA and ET-1 expression of endothelial cells could be prevented by mevalonate with concentration of 100 μmol/L. Conclusion Simvastatin can inhibit ET-1 expression in endothelial cell cultured hypoxically.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2008年第1期72-75,共4页 Journal of Sichuan University(Medical Sciences)
关键词 内皮细胞 内皮素 羟甲基戊二酰辅酶A还原酶抑制剂 辛伐他汀 甲羟戊酸 Endothelial cell Endothelin 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Simvastatin Mevalonate
  • 相关文献

参考文献9

  • 1Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitor. Arterioslcler Thromb Vasc Biol, 2001;21 (11):1712-1719.
  • 2Siegel-Axel DI. Cerlvastatin: a cellular and molecular drug for the future7 Cell Mol Life Sci,2003;60(1):144-164.
  • 3Callahan AS 3rd. Vascular pleitropy of statlns :cllnlcal evidence and biochemical mechanisms. Curr Atheroscler Rep, 2003;5 (1) :33-37.
  • 4Kandoussi A, Martin F, Hazzan M, et al. HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cells. Clin Sci (Lond), 2002;103 (Suppl 48): 81S- 83S.
  • 5Ozaki K, Yamamoto T, Ishibashi T, et al. Regulation of endothelial nitric oxide synthase and endothelial-1 expression by fluvastatin in human vascular endothelial cells. Jpn J Pharmacol, 2001; 85 (2) : 147-154.
  • 6Hernandez-PO, Perez SD, Navarro AJ, et al. Effects of the 3- hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatln, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. Clin Invest,1998;101(12) :2711-2719.
  • 7Karamsetty MR, Pietras L, Kllnger JR, et al. The role of endothelin-1 in straln-related susceptibility to develop hypoxlc pulmonary hypertension in rats. Respir Physlol, 2001; 128(2) : 219-227.
  • 8Ichiki T, Takeda K, Tokunou T, et al. Downregulation of angiotension Ⅰ type 1 receptor by hydrophobic 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle ceils. Arterioscler Thromb Vasc Biol,2001;21 (12) : 1896-1901.
  • 9Shah V, Bharadwa S, Kaibuchi K, et al. Cytoskeletal organization in tro-pomyosin-mediated reversion of rastransformatiom: evidence of Rho kinasa pathway. J Oncogene, 2001 ; 20(17) : 2112-2121.

同被引文献49

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部